PHARMACEUTICAL COMPOSITIONS COMPRISING ALPELISIB
The present invention relates to dispersible tablets comprising the compound (S)-Pyrrolidine- 1,2-dicarboxylic acid 2-amide 1-({4-methyl-5-[2-(2,2,2-trifluoro-1,1-dimethyl-ethyl)-pyridin-4-yl]-thiazol- 2-yl}-amide) or a pharmaceutically acceptable salt thereof. La présente invention concerne des com...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | ELBAZ, FRANTZ STINGELIN, DORIS KOCHHAR, CHARU BOCK, MICHAELA ANNA MARIA |
| description | The present invention relates to dispersible tablets comprising the compound (S)-Pyrrolidine- 1,2-dicarboxylic acid 2-amide 1-({4-methyl-5-[2-(2,2,2-trifluoro-1,1-dimethyl-ethyl)-pyridin-4-yl]-thiazol- 2-yl}-amide) or a pharmaceutically acceptable salt thereof.
La présente invention concerne des comprimés dispersibles comprenant le composé de (S)-Pyrrolidine-1,2-dicarboxylic acid 2-amide 1-({4-méthyl-5-[2-(2,2,2-trifluoro-1,1-diméthyl-éthyl)-pyridin-4-yl]-thiazol- 2-yl}-amide) ou un sel pharmaceutiquement acceptable de celui-ci. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2016051374A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2016051374A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2016051374A13</originalsourceid><addsrcrecordid>eNrjZDAI8HAM8nV0dg0N8XR29FFw9vcN8A_2DPH09wsGc4I8gz393BUcfQJcfYBMJx4G1rTEnOJUXijNzaDs5hri7KGbWpAfn1pckJicmpdaEh_ub2RgaGZgamhsbuJoaEycKgD4dieb</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PHARMACEUTICAL COMPOSITIONS COMPRISING ALPELISIB</title><source>esp@cenet</source><creator>ELBAZ, FRANTZ ; STINGELIN, DORIS ; KOCHHAR, CHARU ; BOCK, MICHAELA ANNA MARIA</creator><creatorcontrib>ELBAZ, FRANTZ ; STINGELIN, DORIS ; KOCHHAR, CHARU ; BOCK, MICHAELA ANNA MARIA</creatorcontrib><description>The present invention relates to dispersible tablets comprising the compound (S)-Pyrrolidine- 1,2-dicarboxylic acid 2-amide 1-({4-methyl-5-[2-(2,2,2-trifluoro-1,1-dimethyl-ethyl)-pyridin-4-yl]-thiazol- 2-yl}-amide) or a pharmaceutically acceptable salt thereof.
La présente invention concerne des comprimés dispersibles comprenant le composé de (S)-Pyrrolidine-1,2-dicarboxylic acid 2-amide 1-({4-méthyl-5-[2-(2,2,2-trifluoro-1,1-diméthyl-éthyl)-pyridin-4-yl]-thiazol- 2-yl}-amide) ou un sel pharmaceutiquement acceptable de celui-ci.</description><language>eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2016</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160407&DB=EPODOC&CC=WO&NR=2016051374A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,778,883,25547,76298</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160407&DB=EPODOC&CC=WO&NR=2016051374A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ELBAZ, FRANTZ</creatorcontrib><creatorcontrib>STINGELIN, DORIS</creatorcontrib><creatorcontrib>KOCHHAR, CHARU</creatorcontrib><creatorcontrib>BOCK, MICHAELA ANNA MARIA</creatorcontrib><title>PHARMACEUTICAL COMPOSITIONS COMPRISING ALPELISIB</title><description>The present invention relates to dispersible tablets comprising the compound (S)-Pyrrolidine- 1,2-dicarboxylic acid 2-amide 1-({4-methyl-5-[2-(2,2,2-trifluoro-1,1-dimethyl-ethyl)-pyridin-4-yl]-thiazol- 2-yl}-amide) or a pharmaceutically acceptable salt thereof.
La présente invention concerne des comprimés dispersibles comprenant le composé de (S)-Pyrrolidine-1,2-dicarboxylic acid 2-amide 1-({4-méthyl-5-[2-(2,2,2-trifluoro-1,1-diméthyl-éthyl)-pyridin-4-yl]-thiazol- 2-yl}-amide) ou un sel pharmaceutiquement acceptable de celui-ci.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2016</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDAI8HAM8nV0dg0N8XR29FFw9vcN8A_2DPH09wsGc4I8gz393BUcfQJcfYBMJx4G1rTEnOJUXijNzaDs5hri7KGbWpAfn1pckJicmpdaEh_ub2RgaGZgamhsbuJoaEycKgD4dieb</recordid><startdate>20160407</startdate><enddate>20160407</enddate><creator>ELBAZ, FRANTZ</creator><creator>STINGELIN, DORIS</creator><creator>KOCHHAR, CHARU</creator><creator>BOCK, MICHAELA ANNA MARIA</creator><scope>EVB</scope></search><sort><creationdate>20160407</creationdate><title>PHARMACEUTICAL COMPOSITIONS COMPRISING ALPELISIB</title><author>ELBAZ, FRANTZ ; STINGELIN, DORIS ; KOCHHAR, CHARU ; BOCK, MICHAELA ANNA MARIA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2016051374A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2016</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>ELBAZ, FRANTZ</creatorcontrib><creatorcontrib>STINGELIN, DORIS</creatorcontrib><creatorcontrib>KOCHHAR, CHARU</creatorcontrib><creatorcontrib>BOCK, MICHAELA ANNA MARIA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ELBAZ, FRANTZ</au><au>STINGELIN, DORIS</au><au>KOCHHAR, CHARU</au><au>BOCK, MICHAELA ANNA MARIA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PHARMACEUTICAL COMPOSITIONS COMPRISING ALPELISIB</title><date>2016-04-07</date><risdate>2016</risdate><abstract>The present invention relates to dispersible tablets comprising the compound (S)-Pyrrolidine- 1,2-dicarboxylic acid 2-amide 1-({4-methyl-5-[2-(2,2,2-trifluoro-1,1-dimethyl-ethyl)-pyridin-4-yl]-thiazol- 2-yl}-amide) or a pharmaceutically acceptable salt thereof.
La présente invention concerne des comprimés dispersibles comprenant le composé de (S)-Pyrrolidine-1,2-dicarboxylic acid 2-amide 1-({4-méthyl-5-[2-(2,2,2-trifluoro-1,1-diméthyl-éthyl)-pyridin-4-yl]-thiazol- 2-yl}-amide) ou un sel pharmaceutiquement acceptable de celui-ci.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2016051374A1 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | PHARMACEUTICAL COMPOSITIONS COMPRISING ALPELISIB |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T01%3A56%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ELBAZ,%20FRANTZ&rft.date=2016-04-07&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2016051374A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |